Orit Berhani

Title: Orit Berhani: Innovator in Autoimmune Disease and Cancer Research

Introduction

Orit Berhani is a prominent inventor based in Jerusalem, Israel. She has made significant contributions to the field of biomedical research, particularly in the development of therapeutic agents for autoimmune diseases and cancer. Her innovative work has led to the filing of a patent that showcases her expertise and dedication to advancing medical science.

Latest Patents

Orit Berhani holds a patent for "Anti-NKP46 antibodies, toxin conjugates, and therapeutic use of same." This patent discloses an affinity binding moiety that comprises an antigen recognition region with specific complementarity determining region (CDR) amino acid sequences. The patent also includes pharmaceutical compositions that utilize this affinity binding moiety as an active ingredient. Furthermore, it outlines methods for diagnosing, preventing, or treating autoimmune diseases or cancers associated with the expression of NKp46.

Career Highlights

Throughout her career, Orit Berhani has worked with esteemed institutions, including Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. and the University of Rijeka Faculty of Medicine. Her work in these organizations has allowed her to collaborate with leading researchers and contribute to groundbreaking studies in her field.

Collaborations

Orit has collaborated with notable colleagues such as Ofer Mandelboim and Stipan Jonjic. These partnerships have enriched her research and expanded the impact of her innovations in the scientific community.

Conclusion

Orit Berhani's contributions to the field of autoimmune disease and cancer research exemplify her commitment to innovation and scientific advancement. Her patent and collaborations highlight her role as a key figure in the development of new therapeutic strategies.